Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Fluorouracil 500mg/10ml solution for injection vials
0801030H0AAARAR
|
Fluorouracil (Antimetabolites) | Fluorouracil (Antimetabolites) | Malignant Disease and Immunosuppression | No data available |
|
Fluorouracil 500mg/20ml inj pre-filled syringes
0801030H0AABGBG
|
Fluorouracil (Antimetabolites) | Fluorouracil (Antimetabolites) | Malignant Disease and Immunosuppression | No data available |
|
Fluorouracil 500mg/20ml solution for injection vials
0801030H0AAADAD
|
Fluorouracil (Antimetabolites) | Fluorouracil (Antimetabolites) | Malignant Disease and Immunosuppression | No data available |
|
Fluorouracil 5g/100ml solution for infusion vials
0801030H0AAAUAU
|
Fluorouracil (Antimetabolites) | Fluorouracil (Antimetabolites) | Malignant Disease and Immunosuppression | No data available |
|
Fluorouracil 600mg/24ml inj pre-filled syringes
0801030H0AABHBH
|
Fluorouracil (Antimetabolites) | Fluorouracil (Antimetabolites) | Malignant Disease and Immunosuppression | No data available |
|
Fluorouracil 800mg/32ml inj pre-filled syringes
0801030H0AABIBI
|
Fluorouracil (Antimetabolites) | Fluorouracil (Antimetabolites) | Malignant Disease and Immunosuppression | No data available |
|
Fluorouracil 900mg/36ml inj pre-filled syringes
0801030H0AABJBJ
|
Fluorouracil (Antimetabolites) | Fluorouracil (Antimetabolites) | Malignant Disease and Immunosuppression | No data available |
|
Fluorouracil 950mg/38ml inj pre-filled syringes
0801030H0AABKBK
|
Fluorouracil (Antimetabolites) | Fluorouracil (Antimetabolites) | Malignant Disease and Immunosuppression | No data available |
|
Foscan 1mg/1ml solution for injection vials
0801050AKBBABAB
|
Foscan | Temoporfin | Malignant Disease and Immunosuppression | No data available |
|
Foscan 20mg/5ml solution for injection vials
0801050AKBBAAAA
|
Foscan | Temoporfin | Malignant Disease and Immunosuppression | No data available |
|
Foscan 3mg/3ml solution for injection vials
0801050AKBBACAC
|
Foscan | Temoporfin | Malignant Disease and Immunosuppression | No data available |
|
Foscan 6mg/6ml solution for injection vials
0801050AKBBADAD
|
Foscan | Temoporfin | Malignant Disease and Immunosuppression | No data available |
|
Fosfestrol 120mg tablets
0803010D0AAADAD
|
Fosfestrol Tetraso | Fosfestrol tetrasodium | Malignant Disease and Immunosuppression | No data available |
|
Fosfestrol 300mg/5ml solution for injection ampoules
0803010D0AAACAC
|
Fosfestrol Tetraso | Fosfestrol tetrasodium | Malignant Disease and Immunosuppression | No data available |
|
Fotivda 1340microgram capsules
0801050CVBBAAAA
|
Fotivda | Tivozanib | Malignant Disease and Immunosuppression | No data available |
|
Fotivda 890microgram capsules
0801050CVBBABAB
|
Fotivda | Tivozanib | Malignant Disease and Immunosuppression | No data available |
|
Futibatinib 4mg tablets
0801050CWAAAAAA
|
Futibatinib | Futibatinib | Malignant Disease and Immunosuppression | No data available |
|
Gazyvaro 1000mg/40ml concentrate for inf vials
0802030G0BBAAAA
|
Gazyvaro | Obinutuzumab | Malignant Disease and Immunosuppression | No data available |
|
Gefitinib 250mg tablets
0801050AWAAAAAA
|
Gefitinib | Gefitinib | Malignant Disease and Immunosuppression | No data available |
|
Gemcitabine 1.5g powder for solution for infusion vials
0801030X0AAACAC
|
Gemcitabine | Gemcitabine | Malignant Disease and Immunosuppression | No data available |
|
Gemcitabine 1g powder for solution for infusion vials
0801030X0AAAAAA
|
Gemcitabine | Gemcitabine | Malignant Disease and Immunosuppression | No data available |
|
Gemcitabine 1g/10ml solution for infusion vials
0801030X0AAAIAI
|
Gemcitabine | Gemcitabine | Malignant Disease and Immunosuppression | No data available |
|
Gemcitabine 1g/25ml solution for infusion vials
0801030X0AAALAL
|
Gemcitabine | Gemcitabine | Malignant Disease and Immunosuppression | No data available |
|
Gemcitabine 1g/26.3ml solution for infusion vials
0801030X0AAAFAF
|
Gemcitabine | Gemcitabine | Malignant Disease and Immunosuppression | No data available |
|
Gemcitabine 200mg powder for solution for infusion vials
0801030X0AAABAB
|
Gemcitabine | Gemcitabine | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.